The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 18, n. 1, 2017. DOI: 10.7175/fe.v18i1.1325. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1325. Acesso em: 29 oct. 2025.